Abstract #0222

Cost-Utility Analysis of Ultrasound, Computed Tomography, Abbreviated and Standard MRI for Hepatocellular Carcinoma Surveillance

An Tang^1,2, Boyan Fan¹, Joshua Bérubé¹, Milena Cerny¹, Damien Olivié¹, Jeanne-Marie Giard³, Luigi Lepanto^1,4, and Jean Lachaine⁵

¹Radiology, University of Montreal, Montreal, QC, Canada, ²Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada, ³Gastroenterology and Hepatology, University of Montreal, Montreal, QC, Canada, ⁴Health Technology Assessment Unit, ⁵Faculty of Pharmacy and Pharmacoeconomics, University of Montreal, Montreal

Current clinical practice guidelines recommend ultrasound (US) every 6 months for surveillance of hepatocellular carcinoma (HCC) in at-risk patients. Despite higher sensitivity, there is uncertainty regarding the role of MRI for HCC surveillance, whether as an add-on or replacement test. Our results indicate that surveillance with standard MRI followed by CT if technically inconclusive provided the highest level of effectiveness. However, CT followed by MRI was more cost-effective than alternative surveillance strategies using a threshold of $50,000 per QALY gained. Further, lower cost of abbreviated MRI will be required to be used as a first-line imaging technique for surveillance.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.